USFDA21 Jul 2025, 05:01 pm
Veerhealth Care Ltd. Commences Execution of Orders in US Market After USFDA Approval
AI Summary
Veerhealth Care Ltd. has started executing orders for its products registered under Drug (OTC) in the US market following approval from the United States Food and Drug Administration (USFDA). The company received the approval on 16th May 2025 and has already dispatched 3 Full Container Load (FCL) shipments. With new orders, the company aims to dispatch 4 to 5 shipments monthly. This development is expected to positively impact the company's revenues and presence in the regulated market.
Key Highlights
- USFDA approval received for Veerhealth Care Ltd.'s products registered under Drug (OTC)
- Company commences execution of orders in the U.S. market
- 3 FCL shipments dispatched as of now
- Company targets to dispatch 4 to 5 shipments monthly
- This development is expected to contribute positively to the Company’s revenues and presence in the regulated market